Analysis Of Salivary Herpesviruses Reveals Associations Between HHV-6 And Long COVID Severity

This study of 45 Long COVID patients and matched controls found that while salivary hormone levels and viral shedding patterns did not differ significantly between groups, higher salivary HHV-6 DNA levels were positively associated with increased Long COVID symptom severity, anxiety, and depression.

The Gist

The Big Picture: A Detective Search in the Mouth

Imagine your body is a city. For years, it has been home to some "old tenants" called Herpesviruses (specifically EBV and HHV-6). These tenants are usually quiet and hide in the walls (your cells), but sometimes they get stressed and start making noise, sending out "smoke signals" (viral DNA) that can be found in your spit.

Scientists wanted to know: Does the amount of smoke these old tenants send out in your saliva explain why some people are still sick months or years after catching COVID-19 (a condition called Long COVID)?

They also wanted to check if the body's "stress hormones" (like cortisol) or "sex hormones" (like testosterone) were acting as the alarm system that wakes these tenants up.

The Setup: Two Groups of Neighbors

The researchers gathered two groups of people:

1. The Long COVID Group: People who still had symptoms more than 6 weeks after getting COVID.
2. The Control Group: People who either never had COVID or recovered completely within 6 weeks.

To make it a fair fight, they matched the groups perfectly by age and gender. Then, they asked everyone to act like a scientist in their own bathroom for two days. They had to spit into a cup at specific times: right when they woke up, 15 minutes later, 30 minutes later, 45 minutes later, and then again 8 and 16 hours after waking.

The Findings: What the "Smoke Signals" Told Us

1. The Morning Rush
Just like a busy coffee shop is busiest in the morning, the study found that these viruses send out the most "smoke signals" (viral DNA) right after you wake up. This happened for everyone, whether they had Long COVID or not.

2. The Hormone Mystery
The researchers checked the "stress and sex hormones" in the spit.

• The Result: They found no major difference between the Long COVID group and the healthy group.
• The Analogy: Imagine checking the fuel gauges of two different cars. You might expect the broken car to have a different fuel level, but in this study, the fuel gauges (hormones) looked exactly the same for both groups. The study did not find evidence that hormone levels were the reason for the lingering sickness.

3. The EBV Tenant (The "Quiet" One)
EBV is a virus that many people have heard of. Previous studies suggested it might be the main culprit behind Long COVID.

• The Result: In this specific study, the amount of EBV in the spit did not differ between the sick and healthy groups.
• The Takeaway: While EBV might have been a troublemaker earlier in the disease (like a riot that happened last week), it doesn't seem to be the one currently making noise in the spit of people who are still sick today.

4. The HHV-6 Tenant (The "Noisy" One)
This is where the study found something interesting.

• The Result: While the presence of HHV-6 didn't perfectly separate the sick from the healthy, the amount of HHV-6 in the spit was linked to how sick the person felt.
• The Analogy: Think of HHV-6 as a tenant who doesn't necessarily break into the house, but the louder they scream, the more the whole neighborhood suffers. The study found that people with higher levels of HHV-6 in their spit reported:
  • More severe overall Long COVID symptoms.
  • Higher levels of anxiety.
  • Higher levels of depression.

The Conclusion: What We Learned

This study is like a snapshot of a specific moment in time. It tells us:

• Hormones aren't the culprit: The body's stress and sex hormone levels in saliva don't seem to be the direct cause of the difference between sick and healthy people in this group.
• EBV might have moved on: The "smoke" from EBV in the mouth doesn't seem to be the main driver of current Long COVID symptoms.
• HHV-6 is a suspect: There is a connection between how much HHV-6 is in the spit and how bad the symptoms (especially mental health ones like anxiety and depression) are.

Important Note: The paper is careful to say this is a correlation, not necessarily a cause. It's like seeing that the more smoke a chimney emits, the more the house smells. It doesn't prove the smoke caused the smell, but it suggests the two are happening together. The researchers suggest that HHV-6 might be playing a role in the "neuropathology" (brain and nerve issues) of Long COVID, but more research is needed to understand exactly how.

In short: The study didn't find a smoking gun for hormones or EBV in the spit, but it did find that the "noise" from HHV-6 seems to travel hand-in-hand with the severity of Long COVID symptoms, particularly anxiety and depression.

Technical Summary

Technical Summary: Analysis of Salivary Herpesviruses Reveals Associations Between HHV-6 and Long COVID Severity

Problem Statement
Reactivation of human herpesviruses (HHVs), particularly Epstein-Barr virus (EBV), has been implicated in the severity of acute SARS-CoV-2 infection and the development of Long COVID (LC). While elevated anti-EBV antibodies and viral DNA in various compartments (blood, throat washes) have been observed in LC patients, the precise relationship between chronic herpesvirus reactivation, salivary shedding dynamics, and specific LC symptom severity remains unclear. Additionally, altered hormonal signaling (cortisol, sex hormones) has been reported in LC, but prior studies often relied on single-timepoint serum samples rather than robust diurnal salivary profiling. This study aims to characterize the salivary shedding dynamics of EBV, HSV-1/2, HCMV, and HHV-6 A/B in relation to LC symptoms and diurnal hormone levels.

Methodology
The study employed a repeated-measures, cross-sectional case-control design involving 45 participants with Long COVID and 45 age- and sex-matched controls. Participants were recruited from the New York City area and enrolled between April 2023 and September 2024.

• Sample Collection: Participants self-collected 12 saliva samples over two consecutive days (6 samples per day) at specific intervals: immediately upon waking, 15, 30, and 45 minutes post-waking, and at 8 and 16 hours post-waking.
• Clinical Assessments: Participants completed validated health questionnaires (e.g., EQ-5D-5L, FSS-7, GAD-7, PHQ-2, GSQ-30) to assess quality of life, fatigue, anxiety, depression, and symptom burden. A Long COVID Propensity Score (LCPS) was constructed using LASSO logistic regression on 14 survey-based measures to quantify symptom severity continuously.
• Laboratory Analysis:
  • Hormones: Salivary cortisol, testosterone, and estradiol were quantified via ELISA. Diurnal metrics, including the Cortisol Awakening Response (CAR) and Area Under the Curve (AUC), were calculated.
  • Viral DNA: Nucleic acids were extracted and tested via multiplex qPCR for EBV, HSV-1/2, HCMV, and HHV-6 A/B. SARS-CoV-2 RNA and human RNaseP were detected via RT-qPCR. Viral positivity required detection in ≥2 samples above the Lower Limit of Quantification (LLOQ).
• Statistical Analysis: Analyses included Wilcoxon rank-sum tests, hierarchical clustering (Gower distance) for symptom profiling, and linear mixed-effects models to account for repeated measures. Bayesian mixed-effects models were used to analyze longitudinal viral shedding. Multiple testing was corrected using the Benjamini-Hochberg (BH) procedure.

Key Results

• Symptom Burden: LC participants reported significantly higher symptom severity across all metrics compared to controls (BH-adjusted p < 0.001), including reduced quality of life, severe fatigue, post-exertional malaise, and cognitive dysfunction. Hierarchical clustering identified low, medium, and high symptom burden groups.
• Hormonal Profiles: No significant differences were found in salivary cortisol, testosterone, or estradiol levels (including CAR and AUC metrics) between LC and control groups. While a trend toward lower whole-day cortisol in LC was observed, it did not reach statistical significance.
• Viral Shedding:
  • Prevalence: Salivary EBV and HHV-6 DNA were detected in 33% and 79% of the cohort, respectively. There were no significant differences in viral positivity rates or mean viral copy numbers between LC and control groups.
  • Diurnal Dynamics: Detection of EBV and HHV-6 DNA was highest immediately upon waking compared to later timepoints.
  • Correlations with Severity: While viral shedding did not distinguish LC from controls, salivary HHV-6 DNA levels were positively associated with higher LCPS scores (R=0.248, adj. p=0.030), indicating a correlation with greater overall symptom severity.
  • Specific Symptoms: Higher HHV-6 copies were nominally associated with increased anxiety (GAD-7) and depression (PHQ-2) scores. No significant associations were found between EBV shedding and LCPS or specific symptom clusters.
• Hormone-Virus Interactions: Higher waking testosterone levels were nominally associated with higher EBV shedding, particularly in males, though this did not survive multiple testing correction.

Significance and Claims
The authors claim that their findings highlight a distinct role for HHV-6 in the pathophysiology of Long COVID, specifically linking salivary HHV-6 shedding to symptom severity and psychological distress (anxiety/depression), rather than simply distinguishing LC patients from healthy controls. The study suggests that while EBV reactivation may play a role in the earlier stages of LC development (consistent with prior antibody findings), persistent HHV-6 reactivation in the saliva may actively contribute to the ongoing symptom burden in the post-acute phase.

The paper emphasizes that the lack of a significant difference in viral shedding between LC and control groups suggests that binary case-control comparisons may be insufficient given the heterogeneity of LC; continuous measures of symptom severity (like LCPS) reveal associations that binary classifications miss. The authors conclude that while mechanisms remain unclear, the observed correlations underscore the need for longitudinal, multi-compartment studies to further investigate herpesvirus reactivation in LC and to evaluate the potential utility of antiviral interventions. The study does not claim causality but posits HHV-6 as a potential contributor to post-acute disease pathology.